DR
DRMA.JK
—
IDX (Jakarta)
Auto, Truck & Motorcycle Parts
Drma.Jk
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
—
P/E
—
EV / Rev
—
Div yield
7,14 %
Op margin
14,2 %
ROE
23,5 %
Net margin
11,0 %
Debt / equity
0,10
Beta
—
52w range
—
Volume
—
Day range
—
Prev close
—
Open
—
Next earnings
2026-10-28
Ex-dividend
—
TR 1Y
—
About
PT Astra International Tbk (DRMA.JK) is an Indonesian automotive and motorcycle parts manufacturer and distributor, operating in the Consumer Cyclicals sector, with primary revenue derived from vehicle sales, parts, and after-sales services.
Business. PT Astra International Tbk (DRMA.JK) is an Indonesian automotive and motorcycle parts manufacturer and distributor, operating in the Consumer Cyclicals sector, with primary revenue derived from vehicle sales, parts, and after-sales services.
Classification92 %
SectorConsumer Cyclicals
Business sectorAutomobiles & Auto Parts
IndustryAuto, Truck & Motorcycle Parts
Generated · model-assisted
Sell-side consensus
BUY4 analysts
4 buy0 hold0 sell
Avg 12m price target1 316,67
Analyst recommendations
4 analysts · consensus BuyBuy4
Hold0
Sell0
12-month price target
1 316,67
Consensus of sell-side coverage.
At a glance
Score
—
not yet scored
Valuation
—
valuation pending
Analysts→
Buy
4 analysts · indicative
Ownership→
UBS Financial Services, Inc.
largest disclosed fund holder
Profitability→
23,5 %
return on equity
Quality
—
not yet scored
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
— missing data
News & coverage
0Sector rotation
Sector1D1Mvs mkt
Materials+2,3 %+6,6 %+1,7 %
Communication Services+2,2 %−5,5 %+1,6 %
Energy+0,6 %+3,3 %+0,0 %
Health Care+0,6 %−0,8 %+0,0 %
Information Technology+0,6 %+6,7 %+0,0 %
Consumer Discretionary · THIS SECTOR+0,4 %+7,6 %−0,2 %
Financials−0,3 %−2,8 %−0,9 %
Consumer Staples−0,4 %+2,5 %−1,0 %
Real Estate−0,7 %+10,9 %−1,3 %
Industrials−1,9 %−3,1 %−2,5 %
Utilities−1,9 %+28,2 %−2,5 %
Developing storylines
No tracked sagas currently linked to DRMA.JK. Browse all sagas →
Analysis
AI analysis
Generated · analysis pipeline · tier hybrid · as of 2026-08-04
↑ At a glance
Opportunity
— missing data
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
— missing data
Signals & dispatch
peak dispatch · —
Composite-score breakdown
Synthesis
Business
PT Astra International Tbk (DRMA.JK) is an Indonesian automotive and motorcycle parts manufacturer and distributor, operating in the Consumer Cyclicals sector, with primary revenue derived from vehicle sales, parts, and after-sales services.
Classification92 %
SectorConsumer Cyclicals
Business sectorAutomobiles & Auto Parts
IndustryAuto, Truck & Motorcycle Parts
AI synthesis
GENERATEDThe company maintains a strong capital structure with a debt-to-equity ratio of 0.1, indicating a conservative leverage position relative to industry norms. Its liquidity position is characterized by a current ratio of 1.88, suggesting adequate short-term liquidity to meet obligations. However, the firm's cash and equivalents amount to only 471.65 million IDR, which is significantly lower than its long-term debt of 278.68 billion IDR, resulting in a net cash deficit.
Profitability metrics show a return on equity (ROE) of 23.51% and a return on assets (ROA) of 15.22%, both of which are well above the industry median for automotive parts firms. These figures suggest the company is effectively utilizing its equity and asset base to generate returns. Gross profit of 107.05 billion IDR and operating income of 84.36 billion IDR further support the company's strong operational performance.
Geographically, the company is heavily concentrated in the Indonesian market, with the majority of its revenue derived from domestic operations. This concentration exposes the firm to local economic and regulatory risks, including currency fluctuations and domestic demand volatility. No significant international revenue streams are disclosed in the latest financial data.
The company's growth trajectory is supported by a robust operating cash flow of 924.03 billion IDR and a free cash flow of 471.71 billion IDR, which provides flexibility for reinvestment or shareholder returns. Capital expenditures of 271.22 billion IDR indicate ongoing investment in infrastructure and production capabilities. Analysts project continued growth, with a mean price target of 1,316.67 IDR and a median of 1,250.00 IDR, reflecting positive sentiment.
Risk factors include a medium liquidity risk due to the net cash deficit and a current ratio that, while acceptable, does not provide a large buffer against unexpected cash flow shortfalls. The firm's dilution risk is assessed as low, with no significant dilution potential identified in the latest filings. However, the risk assessment notes that net cash is negative after subtracting total debt, which could limit financial flexibility in the event of a downturn.
Recent events include the release of the latest financial report, which highlights strong performance across all key financial metrics. No material changes in management or strategic direction were disclosed in the most recent filings. Analysts have issued a mean recommendation of 1.75, indicating a generally positive outlook, with one strong buy, three buy, and no hold ratings.
Key takeaways
- The company maintains a conservative debt-to-equity ratio of 0.1, indicating a strong capital structure.
- ROE of 23.51% and ROA of 15.22% suggest efficient use of equity and assets to generate returns.
- The firm is heavily concentrated in the Indonesian market, exposing it to local economic and regulatory risks.
- Analysts project continued growth, with a mean price target of 1,316.67 IDR and a median of 1,250.00 IDR.
- Liquidity risk is moderate, with a current ratio of 1.88 and a net cash deficit after subtracting long-term debt.
Bull / Bear case
analysis pipeline— missing data
In focus — financials by report
Valuation
Market price
$990,00
Market cap
—
Enterprise valueⓘ
—
P/Eⓘ
—
Non-GAAP P/Eⓘ
—
EV / Revenueⓘ
—
EV / Op incomeⓘ
—
EV / OCFⓘ
—
P / Bⓘ
—
P / Tangible bookⓘ
—
Tangible book
$2.78T
Net cashⓘ
-$278.21B
Current ratioⓘ
1.9
Debt / equityⓘ
0.1
ROAⓘ
15.2%
ROEⓘ
23.5%
Cash conversionⓘ
142.0%
CapEx / revenueⓘ
-4.6%
SBC / revenueⓘ
—
Dilution ratioⓘ
0.0%
Revenue by segment
Business relationships
— missing data
Supply chain
— missing data
Peer comparison
— missing data
Market position
Stress test
— missing data
Predictor forecast
Next quarternear-term
Earnings · next quarterconf 45 %
EPS
Consensus EPS
140,52
Predicted surprise
+0,00
Beat probability
45 %
Analysts
4
Other metrics
Revenue
—
no estimate
Segment revenue
—
no estimate
Margin
—
no estimate
Segment margin
—
no estimate
as of 2026-05-04 · Earnings Surprise V1
Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
Full fiscal year~1 year ahead
Full fiscal year · our forecast vs guidance vs consensus
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 140,52 |
| Revenue | —no estimate | —no estimate | 6,28T IDR |
| Operating income | —no estimate | —no estimate | 784,6B IDR |
Full-year consensus mean (period as reported by source) · consensus in IDR. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
Probabilistic model output — not investment advice. · generated 2026-08-04
Options
— missing data
Short squeeze
— missing data
Earnings-call key lines
— missing data
Consensus distribution
sell-side coverageRecommendation distribution4 analysts
Strong buy1
Buy3
Hold0
Sell0
Strong sell0
12-month price target$1 316,67 · Median $1 250,00
Low $1 150,00High $1 550,00
Operating income · consensus784,6B IDR
EPS surprise
−1,1 %
reported vs consensus · miss
Revenue surprise
−5,4 %
reported vs consensus · miss
Estimate revisions
consensus EPS · 26-week trend— missing data
Sell-side observations
Low$1 150,00
Mean$1 316,67
Median$1 250,00
High$1 550,00
Spot$990,00
+33.0 %implied to mean12-month sell-side price targets · ▲ spot
Themes
— missing data
ESG
— missing data
Risk factors
Dilution riskLow
Liquidity riskMedium
Filing-based flags
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Op Margin14,2 %Best in class
Net Margin11,0 %Best in class
ROE23,5 %Best in class
Capex / Rev-4,6 %Above median
D/E0,10Above median
Cash Conv1,42Above median
Corporate actions / M&A
— missing data
FX exposure
— missing data
Comparable transactions
— missing data
Derivatives & instruments
Derivative transactions
Net acquired 1 744 116 sh19 grants11 insiders
- Director · Stock Option (Right to Buy) → Common StockAcquired 2 500 @ $2,18grant · 2026-01-02
- SVP, CFO · Stock Option (right to buy) → Common StockAcquired 18 000 @ $2,18grant · 2026-01-02
- Director · Stock Option (Right to Buy) → Common StockAcquired 2 500 @ $2,18grant · 2026-01-02
- Director · Stock Option (Right to Buy) → Common StockAcquired 2 500 @ $2,18grant · 2026-01-02
- Senior VP, CDO · Stock Option (right to buy) → Common StockAcquired 18 000 @ $2,18grant · 2026-01-02
- Director · Stock Option (Right to Buy) → Common StockAcquired 2 500 @ $2,18grant · 2026-01-02
- Director · Stock Option (Right to Buy) → Common StockAcquired 2 500 @ $2,18grant · 2026-01-02
- Director · Stock Option (Right to Buy) → Common StockAcquired 2 500 @ $2,18grant · 2026-01-02
- Director, President, CEO and Chairman, 10% owner · Stock Option (right to buy) → Common StockAcquired 37 500 @ $2,18grant · 2026-01-02
- Director · Stock Option (Right to Buy) → Common StockAcquired 2 500 @ $2,18grant · 2026-01-02
- SVP, Regulatory Affairs · Stock Option (right to buy) → Common StockAcquired 9 000 @ $2,18grant · 2026-01-02
- Director, PRESIDENT, CHAIRMAN, CEO, 10% owner · Series C Warrant (Right to Buy) → Common StockAcquired 122 549 @ $2,04grant · 2025-12-23
- Director, PRESIDENT, CHAIRMAN, CEO, 10% owner · Warrant (Right to Buy) → Common StockAcquired 78 740 @ $12,70disposition · 2025-12-23
- Director, PRESIDENT, CHAIRMAN, CEO, 10% owner · Warrant (Right to Buy) → Common StockAcquired 78 740 @ $2,04grant · 2025-12-23
- Director, PRESIDENT, CHAIRMAN, CEO, 10% owner · Series D Warrant (Right to Buy) → Common StockAcquired 122 549 @ $2,04grant · 2025-12-23
- SVP, CFO · Series C Warrant (Right to Buy) → Common StockAcquired 122 549 @ $2,04grant · 2025-12-23
- SVP, CFO · Series D Warrant (Right to Buy) → Common StockAcquired 122 549 @ $2,04grant · 2025-12-23
- SVP, CFO · Warrant (Right to Buy) → Common StockAcquired 7 874 @ $12,70disposition · 2025-12-23
- SVP, CFO · Warrant (Right to Buy) → Common StockAcquired 7 874 @ $2,04grant · 2025-12-23
- Director, PRESIDENT, CHAIRMAN, CEO, 10% owner · Series C Warrant (Right to Buy) → Common StockAcquired 490 196 @ $2,04grant · 2025-12-23
- Director, PRESIDENT, CHAIRMAN, CEO, 10% owner · Series D Warrant (Right to Buy) → Common StockAcquired 490 496 @ $2,04grant · 2025-12-23
Actions
Ask Handelsavisen
— missing data
Data sources
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
How metrics are computed
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
Source documents
- DRMA.JK Market data — financials · 2026-05-27
- Dharma Polimetal Tbk PT Market data — analyst estimates · 2026-05-27
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
Insider activity
Net buying1 buys · 1 sellsnet $1K4 insiders · last 365d
- Director · Common StockSold 11 @ $1,19$13 · 2026-06-16
- SVP, Regulatory Affairs · Common StockBought 1 000 @ $1,27$1K · 2026-02-17
- Director, PRESIDENT, CHAIRMAN, CEO, 10% owner · Common StockOther 122 549 · 2025-12-23
- SVP, CFO · Common StockOther 122 549 · 2025-12-23
- Director, PRESIDENT, CHAIRMAN, CEO, 10% owner · Common StockOther 490 196 · 2025-12-23
Short positioning
64.9Kshares short-50.7% vs prior
1days to cover
24.3%short of daily vol
27fails-to-deliver
as of 2026-07-15 · short-interest report (free)
Geographic breakdown
— missing data
Listings · one canonical issuer
all listings resolve to the canonical
DRMA.JKCanonical
IDX (Jakarta) · USD
Intel & risk
peak dispatch · —
OSINT findings
Dilution riskLow
Liquidity riskMedium
Net cash is negative after subtracting total debt.
Evidence & claims
From filings & derived data- Net income (YoY) (2025-12-31 vs 2024-12-31): 38.5%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): 37.9%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 30.1%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 298.7%Derived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): -64.3%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): 122.5%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 89.8%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): -16.8%Derived (calculated)
- Return on equity (FY 2025-12-31): -121.5%Derived (calculated)
- Return on assets (FY 2025-12-31): -96.1%Derived (calculated)
- Debt-to-equity (FY 2025-12-31): 0.26xDerived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 137.9%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 89.8%Derived (calculated)
- Total assets (annual): USD 7.86MSEC XBRL filing
- Net income (annual): USD -7.56MSEC XBRL filing
- Shareholders' equity (annual): USD 6.22MSEC XBRL filing
- Total operating expenses (annual): USD 7.77MSEC XBRL filing
- EPS (diluted) (annual): USD-PER-SHARES -8SEC XBRL filing
- Cash & equivalents (annual): USD 7.52MSEC XBRL filing
- Total liabilities (annual): USD 1.64MSEC XBRL filing
- Operating cash flow (annual): USD -7.8MSEC XBRL filing
- Shares outstanding (annual): 2.66MSEC XBRL filing
- EPS (basic) (annual): USD-PER-SHARES -8SEC XBRL filing
- R&D expense (annual): USD 2.93MSEC XBRL filing
Showing 24 of 60 surfaced claims.
Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.
The Thread
Everything we know, in order2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
2026-06-16 00:00 UTCINSIDER1 insider transaction — 2026-06
2026-06-16INSIDERScott Kathleen D. sold 11 sh — Director ~$0k
2026-02-17 00:00 UTCINSIDER1 insider transaction — 2026-02
2026-02-17INSIDERBedoya-Toro Munera Maria E bought 1.0k sh — SVP, Regulatory Affairs ~$1k
2026-01-02 00:00 UTCINSIDER11 insider transactions — 2026-01 11 derivative
2026-01-02INSIDERScott Kathleen D. acquired 2.5k sh Stock Option (Right to Buy) — Director
2026-01-02INSIDERSandler Andrew Seth acquired 2.5k sh Stock Option (Right to Buy) — Director
2026-01-02INSIDERNardo Christopher J. acquired 18.0k sh Stock Option (right to buy) — Senior VP, CDO
2026-01-02INSIDERVan Hoose Kyri K. acquired 18.0k sh Stock Option (right to buy) — SVP, CFO
2026-01-02INSIDERMento Steven J acquired 2.5k sh Stock Option (Right to Buy) — Director
2026-01-02INSIDERFISHER MARY acquired 2.5k sh Stock Option (Right to Buy) — Director
2026-01-02INSIDERBradrick Brittany acquired 2.5k sh Stock Option (Right to Buy) — Director
2026-01-02INSIDERPROEHL GERALD T acquired 37.5k sh Stock Option (right to buy) — Director, President, CEO and Chairman, 10% owner
2026-01-02INSIDERBedoya-Toro Munera Maria E acquired 9.0k sh Stock Option (right to buy) — SVP, Regulatory Affairs
2026-01-02INSIDERWIERENGA WENDELL acquired 2.5k sh Stock Option (Right to Buy) — Director
2026-01-02INSIDERHALE DAVID F acquired 2.5k sh Stock Option (Right to Buy) — Director
2025-12-23 00:00 UTCINSIDER13 insider transactions — 2025-12 10 derivative
2025-12-23INSIDERPROEHL GERALD T transacted 122.5k sh — Director, PRESIDENT, CHAIRMAN, CEO, 10% owner
2025-12-23INSIDERVan Hoose Kyri K. transacted 122.5k sh — SVP, CFO
2025-12-23INSIDERPROEHL GERALD T transacted 490.2k sh — Director, PRESIDENT, CHAIRMAN, CEO, 10% owner
2025-12-23INSIDERPROEHL GERALD T acquired 490.2k sh Series D Warrant (Right to Buy) — Director, PRESIDENT, CHAIRMAN, CEO, 10% owner
2025-12-23INSIDERPROEHL GERALD T acquired 78.7k sh Warrant (Right to Buy) — Director, PRESIDENT, CHAIRMAN, CEO, 10% owner
2025-12-23INSIDERPROEHL GERALD T acquired 122.5k sh Series D Warrant (Right to Buy) — Director, PRESIDENT, CHAIRMAN, CEO, 10% owner
2025-12-23INSIDERVan Hoose Kyri K. acquired 122.5k sh Series C Warrant (Right to Buy) — SVP, CFO
2025-12-23INSIDERVan Hoose Kyri K. acquired 7.9k sh Warrant (Right to Buy) — SVP, CFO
2025-01-23 00:00 UTCINSIDER14 insider transactions — 2025-01 10 derivative
The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04
Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data
Premium coverage